Hap Trading, LLC Novavax Inc Put Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$18.2 - $76.12 $111,020 - $464,332	-6,100 Reduced 4.48%	130,000 $10.7 Million
Q2 2022 Aug 12, 2022	SELL	$36.28 - $75.29 $2.76 Million - $5.72 Million	-76,000 Reduced 35.83%	136,100 $7.46 Million
Q1 2022 May 12, 2022	BUY	$69.73 - $142.9 $1.9 Million - $3.89 Million	27,200 Added 14.71%	212,100 $12.7 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $14.1 Million - $22.9 Million	104,900 Added 131.13%	184,900 $6.64 Million
Q3 2021 Nov 10, 2021	BUY	$177.8 - $270.58 $1.26 Million - $1.92 Million	7,100 Added 9.74%	80,000 $1.8 Million
Q2 2021 Aug 11, 2021	BUY	$121.0 - $257.67 $6.8 Million - $14.5 Million	56,200 Added 336.53%	72,900 $1.94 Million
Q1 2021 May 14, 2021	SELL	$112.98 - $319.93 $937,734 - $2.66 Million	-8,300 Reduced 33.2%	16,700 $431,000
Q4 2020 Feb 16, 2021	SELL	$78.74 - $139.5 $417,322 - $739,350	-5,300 Reduced 17.49%	25,000 $149,000
Q3 2020 Nov 13, 2020	SELL	$79.44 - $178.51 $278,040 - $624,785	-3,500 Reduced 10.36%	30,300 $205,000
Q2 2020 Aug 10, 2020	BUY	$13.86 - $83.61 $260,568 - $1.57 Million	18,800 Added 125.33%	33,800 $98,000
Q1 2020 May 08, 2020	BUY	$3.93 - $16.0 $58,950 - $240,000	15,000 New	15,000 $6,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.